newsfilter
← Latest News
FDA Approved Drugs·

Approval of Gleevec, Nda #021588 (Labeling)

Approval Date: 07/13/2026; Drug Name: Gleevec, Nda #021588; Active Ingredients: IMATINIB MESYLATE; Company: Novartis; Submission Status: Approval; Submission Classification: Labeling; Application Number: 021588

Company
NOVARTIS
Keywords
NOVARTIS